Eur Rev Med Pharmacol Sci 2019; 23 (5): 1841-1844
DOI: 10.26355/eurrev_201903_17217

Evaluation of genotyping methods and costs for MTHFR, CBS and MTRR polymorphisms in patients with vitiligo

S. Di Martino, T. Muto, V. de Lucia

Pathology Unit, Santa Maria della Pietà Hospital, Nola (ASL NA 3 SUD), Naples, Italy. salvo-dimartino@libero.it

Free PDF Download

To cite this article

S. Di Martino, T. Muto, V. de Lucia
Evaluation of genotyping methods and costs for MTHFR, CBS and MTRR polymorphisms in patients with vitiligo

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 5
Pages: 1841-1844
DOI: 10.26355/eurrev_201903_17217

Keywords Related articles:

  1. High incidence of MTHFR, CBS, and MTRR polymorphisms in vitiligo patients. Preliminary report in a retrospective study
  2. Evaluation of genotyping methods and costs for VDR polymorphisms
  3. Evaluation of genotyping methods and costs for IL1α polymorphisms in Platelet Rich-Plasma (PRP); viewpoint for therapy on the diabetic foot ulcers
  4. Evaluation of genotyping methods and the relative cost of pharmacogenomics
  5. Evaluation methods on the nutritional status of stroke patients